Dedalus NHS Humber EPR implementation is underway after NHS Humber Health Partnership selected...
Author - Abby Davey
Interim Phase 2 data show functional improvement with IMM01-STEM...
Immunis has reported interim Phase 2 clinical data showing improvements in physical function among...
Wave Life Sciences 2026 strategic priorities accelerate WVE-007...
Wave Life Sciences 2026 strategic priorities were outlined by the company at the 44th Annual J.P...
Novartis ianalumab receives FDA Breakthrough Therapy designation...
Novartis has received US Food and Drug Administration Breakthrough Therapy designation for...
Agentic AI gap highlighted across life sciences and pharma...
Life sciences and pharmaceutical organisations report a growing gap between their ambitions for...
Jasper Therapeutics reports positive briquilimab data in chronic...
Jasper Therapeutics has reported updated clinical data showing disease control in patients treated...
Beacon Therapeutics Series C financing raises over $75 million
Beacon Therapeutics has secured more than $75 million in Series C financing to advance the...
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...
Lilly Phase 3 trial shows oral GLP-1 maintains weight loss after...
Eli Lilly has reported Phase 3 results showing that its investigational oral GLP-1 therapy...